Does diagnosing celiac disease without a biopsy affect follow-up?
In 54 children, blood-test-only celiac diagnosis led to similar follow-up and antibody drops as diagnosis with a biopsy over 2 years.
The study followed children at Seattle Children’s Hospital. Their average age at diagnosis was 9.7 years. Of these, 32 had a biopsy, which checks a small tissue sample. The other 22 were diagnosed through blood tests alone. All had ongoing follow-up for two years after diagnosis.
Researchers tracked TTG IgA, an antibody blood test used for celiac disease. Every child started at least 10 times above the test’s normal upper limit. Starting levels were similar between groups. Levels fell in both groups, with no clear difference at any measured time. The report did not give exact amounts for these drops.
Follow-up care was also similar. Neither group had a clear difference in time to the first dietitian visit. The number of dietitian visits over 24 months was similar, too. The main takeaway is about care after diagnosis, not whether everyone can skip a biopsy.
For this community, one test distinction matters. TTG IgA measures a specific antibody, not total Immunoglobulin A (IgA). These results do not show that total antibody levels fell. They also come from a small group with very high starting test results.
For members tracking celiac bloodwork, test names and dates can make comparisons more useful. Sharing starting results, later values, and follow-up timing adds context beyond one number. Comparing notes may also reveal how care experiences differ, even when blood test trends look alike.
What changes have you seen in your celiac blood tests during follow-up, and how was your diagnosis made?

Comments
No comments yet.